Subscribe

AxoGen, Inc. (AXGN)

USD39.37 -0.12 (-0.29%)
US NASDAQ Healthcare Medical - Devices
Address 13631 Progress Boulevard 32615
Alachua, FL, US
CEO Michael D. Dale
IPO 1986-12-17
CIK 805928 ISIN US05463X1063

Explore sections of this company profile

Also trades on London Stock Exchange · 0HKD.L (USD) NASDAQ Capital Market · AXGN (USD)
Description

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.

Market Cap & Enterprise Value
Merger & Acquisition History
Target company Ticker Date Filing
Nerve LECT 2011-07-06 View
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD39.37 -0.12 (-0.29%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.12
Float Shares
51.90M
Free Float %
97.6%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.33% -3.85% -8.61% +24.42% +37.80% +20.62% +262.53% +353.27% +99.80% +610.07% +887.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (19 ratings, all time) Buy
Price Targets & DCF
Current price
39.37
Low 36.00 -8.6%
Consensus 43.43 +10.3%
Median 40.00 +1.6%
High 50.00 +27.0%
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 2 0
Buy 7 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter 4
48.25
+22.5%
Last Year 16
38.38
-2.5%
All Time 16
38.38
-2.5%
Quality scores
Altman Z-Score
29.49
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Devices: +11.2%
    +20.2% Q1'26: +26.6% (vs Q1'25)
  • EPS growth Medical - Devices: +28.5%
    -47.8% Q1'26: -348.1% (vs Q1'25)
  • FCF margin FCF growth · Medical - Devices: +30.9%
    -15.9% Q1'26: -2.0% (vs Q1'25)
  • EBIT margin Medical - Devices: +6.2%
    -3.6% Q1'26: -4.6% (vs Q1'25)
  • ROIC Medical - Devices: +3.3%
    -7.1% Q1'26: -6.2% (vs Q1'25)
  • Share dilution Medical - Devices: 0.0%
    +4.1% Q1'26: +14.1% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    100.22× Q1'26: -1.82× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.17) × ERP
WACC = 99% × Ke + 1% × Kd (40.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 39.37
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
7 Rev. Ana.
5 EPS Ana.
Dec 2027
7 Rev. Ana.
5 EPS Ana.
Dec 2028
5 Rev. Ana.
4 EPS Ana.
Dec 2029
2 Rev. Ana.
2 EPS Ana.
Dec 2030
2 Rev. Ana.
2 EPS Ana.
Revenue
27.33M
est: 27.16M (+0.6%)
41.11M
est: 40.67M (+1.1%)
60.43M
est: 59.44M (+1.7%)
83.94M
est: 84.30M (-0.4%)
106.71M
est: 107.31M (-0.6%)
112.30M
est: 110.08M (+2.0%)
127.36M
est: 127.56M (-0.2%)
138.58M
est: 138.65M (0.0%)
159.01M
est: 173.48M (-8.3%)
187.34M
est: 186.45M (+0.5%)
225.21M
est: 224.36M (+0.4%)
270.84M
267.02M – 273.58M
+20.7% YoY
318.64M
310.01M – 328.85M
+17.6% YoY
378.06M
377.93M – 378.19M
+18.6% YoY
444.67M
436.71M – 453.39M
+17.6% YoY
554.60M
544.68M – 565.49M
+24.7% YoY
EBITDA
-8.99M
est: -9.26M (+2.9%)
-7.69M
est: -7.44M (-3.4%)
-7.42M
est: -7.65M (+3.0%)
-20.34M
est: -18.60M (-9.4%)
-26.22M
est: -29.10M (+9.9%)
-19.27M
est: -22.25M (+13.4%)
-20.89M
est: -25.11M (+16.8%)
-23.47M
est: -29.17M (+19.6%)
-13.33M
est: -13.32M (-0.1%)
6.08M
est: -14.32M (+142.5%)
192.0K
est: -17.23M (+101.1%)
-20.79M
-21.01M – -20.50M
-20.7% YoY
-24.46M
-25.25M – -23.80M
-17.6% YoY
-29.03M
-29.04M – -29.02M
-18.6% YoY
-34.14M
-34.81M – -33.53M
-17.6% YoY
-42.58M
-43.42M – -41.82M
-24.7% YoY
EBIT
-9.24M
est: -9.55M (+3.2%)
-8.15M
est: -7.85M (-3.8%)
-7.98M
est: -8.22M (+2.9%)
-21.19M
est: -18.47M (-14.7%)
-29.10M
est: -35.00M (+16.9%)
-22.73M
est: -27.48M (+17.3%)
-25.63M
est: -30.71M (+16.5%)
-28.32M
est: -35.43M (+20.0%)
-18.88M
est: -19.75M (+4.4%)
-1.76M
est: -21.23M (+91.7%)
-8.00M
est: -25.54M (+68.7%)
-30.84M
-31.15M – -30.40M
-20.7% YoY
-36.28M
-37.44M – -35.30M
-17.6% YoY
-43.04M
-43.06M – -43.03M
-18.6% YoY
-50.63M
-51.62M – -49.72M
-17.6% YoY
-63.14M
-64.38M – -62.01M
-24.7% YoY
Net Income
-13.36M
est: -13.80M (+3.2%)
-14.41M
est: -13.71M (-5.2%)
-10.45M
est: -10.90M (+4.1%)
-22.40M
est: -20.58M (-8.8%)
-29.12M
est: -32.39M (+10.1%)
-23.79M
est: -28.77M (+17.3%)
-26.99M
est: -32.48M (+16.9%)
-28.95M
est: -23.47M (-23.4%)
-21.72M
est: -17.63M (-23.2%)
-9.96M
est: 3.58M (-378.5%)
-15.70M
est: 14.22M (-210.4%)
22.67M
18.36M – 26.97M
+59.4% YoY
33.10M
27.52M – 38.68M
+46.0% YoY
12.85M
-51.17M – 133.03M
-61.2% YoY
48.97M
47.83M – 50.22M
+280.9% YoY
54.34M
53.08M – 55.73M
+11.0% YoY
SGA
28.51M
est: 20.95M (+36.1%)
38.56M
est: 38.16M (+1.1%)
52.37M
est: 56.13M (-6.7%)
79.74M
est: 72.17M (+10.5%)
103.26M
est: 82.76M (+24.8%)
96.06M
est: 84.90M (+13.1%)
105.67M
est: 98.38M (+7.4%)
112.89M
est: 133.21M (-15.3%)
115.99M
est: 126.05M (-8.0%)
117.50M
est: 135.47M (-13.3%)
142.32M
est: 163.01M (-12.7%)
196.79M
194.01M – 198.78M
+20.7% YoY
231.52M
225.24M – 238.93M
+17.6% YoY
274.69M
274.59M – 274.78M
+18.6% YoY
323.08M
317.30M – 329.42M
+17.6% YoY
402.96M
395.75M – 410.87M
+24.7% YoY
EPS
-0.51
est: -0.50 (-3.0%)
-0.47
est: -0.38 (-24.8%)
-0.31
est: -0.33 (+4.8%)
-0.60
est: -0.54 (-11.9%)
-0.74
est: -0.41 (-81.4%)
-0.60
est: -0.43 (-39.2%)
-0.65
est: -0.45 (-43.8%)
-0.69
est: -0.38 (-79.9%)
-0.51
est: -0.38 (-33.4%)
-0.23
est: 0.08 (-379.6%)
-0.34
est: 0.31 (-210.1%)
0.50
0.40 – 0.59
+60.7% YoY
0.72
0.60 – 0.84
+44.8% YoY
0.97
-1.11 – 2.89
+34.5% YoY
1.06
1.04 – 1.09
+10.0% YoY
1.18
1.15 – 1.21
+11.0% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-04-29 Citizens Market Outperform Market Outperform Maintain
2026-04-23 Lake Street Buy Buy Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-28 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-27 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-26 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-22 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-21 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-20 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-19 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-18 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-15 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-14 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-13 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-12 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-11 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-08 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-07 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-06 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-05 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-04 C- 1/5 1/5 1/5 1/5 3/5 1/5 1/5
2026-05-01 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-16 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-15 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-04-14 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
31.28M
OE per share TTM
0.67
Owner's Yield
1.54%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
51.3%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
222
Total invested
1.65B
Insider transactions (90d)
7
Beneficial owners (>5%)
20
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 ArrowMark Colorado Holdings, LLC 5.66M 13.62% 5.66M 5.66M IA Delaware, United States 2022-02-14
2 First Light Asset Management, LLC 4.36M 9.96% 4.36M IA Delaware 2024-11-07
3 Mathew P. Arens 4.36M 9.96% 4.36M IN Delaware 2024-11-07
4 Group, LLC 3.54M 8.20% 3.54M 3.54M OO 2023-08-11
5 LLC 3.54M 8.20% 3.54M 3.54M OO 2023-08-11
6 Levy 3.54M 8.20% 3.54M IN 2023-08-11
7 Master Fund, L.P. 3.54M 8.20% 3.54M 3.54M FI 2023-08-11
8 (1) BlackRock, Inc. 3.01M 7.20% 2.96M 3.01M HC Delaware 2022-02-01
9 Morgan Stanley 2.86M 6.60% 13.00 13.00 HC, CO 2024-02-12
10 Morgan Stanley Capital Services LLC 2.75M 6.40% 13.00 13.00 BD, CO 2024-02-12
11 The Vanguard Group - 23-1945930 2.47M 5.73% 2.38M 83.2K IA Pennsylvania 2024-02-13
12 Steven A. Cohen 2.11M 4.00% 2.11M 2.11M IN Delaware 2022-06-21
13 Point72 Asset Management, L.P. 2.07M 4.00% 2.07M 2.07M PN Delaware 2022-06-21
14 Point72 Capital Advisors, Inc. 2.07M 4.00% 2.07M 2.07M CO Delaware 2022-06-21
15 Cubist Systematic Strategies, LLC 36.7K 4.00% 36.7K 36.7K OO Delaware 2022-06-21
16 Point72 Hong Kong Limited 2.7K 4.00% 2.7K 2.7K OO Delaware 2022-06-21
17 Consonance Capital Management LP 0.00% IA, PN Delaware USA 2021-02-17
18 Consonance Capital Opportunity Fund Management LP 0.00% IA, PN Delaware USA 2021-02-17
19 Consonance Capman GP LLC 0.00% HC, OO Delaware USA 2021-02-17
20 Mitchell Blutt 0.00% HC, IN Delaware USA 2021-02-17

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
222
+10 vs prev Q
New positions
48
Closed positions
36
Increased
130
Reduced
65
Put/Call ratio
0.00
Calls held
50.6K
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 FIRST LIGHT ASSET MANAGEMENT, LLC 5.23M -572.4K (-9.9%) 171.29M +67.7M (+65.4%) 11.40% -1.330 pp 13.10% +3.332 pp USD11.64 +181.2% 22 qtrs
2 BLACKROCK, INC. 3.72M +110.3K (+3.1%) 121.74M +57.3M (+89.1%) 8.10% +0.189 pp 0.00% +0.001 pp USD14.86 +120.3% 6 qtrs
3 VANGUARD GROUP INC 2.87M +190.6K (+7.1%) 93.93M +46.1M (+96.5%) 6.25% +0.377 pp 0.00% +0.001 pp USD14.85 +120.4% 50 qtrs
4 MORGAN STANLEY 2.59M +157.0K (+6.5%) 84.67M +41.3M (+95.3%) 5.64% +0.307 pp 0.01% +0.002 pp USD10.24 +219.6% 49 qtrs
5 ARROWMARK COLORADO HOLDINGS LLC 1.47M -484.1K (-24.7%) 48.25M +13.3M (+38.1%) 3.21% -1.083 pp 1.06% +0.413 pp USD16.00 +104.6% 32 qtrs
6 ASSENAGON ASSET MANAGEMENT S.A. 1.38M +90.8K (+7.0%) 45.16M +22.2M (+96.4%) 3.01% +0.179 pp 0.06% +0.031 pp USD12.95 +152.7% 23 qtrs
7 SOLEUS CAPITAL MANAGEMENT, L.P. 1.21M -519.7K (-30.1%) 39.50M +8.7M (+28.2%) 2.63% -1.157 pp 1.46% -0.094 pp USD9.15 +257.7% 14 qtrs
8 GEODE CAPITAL MANAGEMENT, LLC 1.10M +16.1K (+1.5%) 35.87M +16.6M (+86.2%) 2.39% +0.020 pp 0.00% +0.001 pp USD14.62 +123.9% 45 qtrs
9 STATE STREET CORP 1.08M -34.5K (-3.1%) 35.21M +15.4M (+77.8%) 2.34% -0.091 pp 0.00% +0.001 pp USD16.42 +99.3% 39 qtrs
10 MILLENNIUM MANAGEMENT LLC 971.4K +930.1K (+2,255.8%) 31.79M +31.1M (+4,222.1%) 2.12% +2.026 pp 0.01% +0.013 pp USD31.80 +2.9% 27 qtrs
11 ARMISTICE CAPITAL, LLC 936.0K -264.0K (-22.0%) 30.64M +9.2M (+43.1%) 2.04% -0.592 pp 0.36% +0.047 pp USD13.17 +148.5% 6 qtrs
12 WASATCH ADVISORS LP 923.6K -715.8K (-43.7%) 30.23M +982.5K (+3.4%) 2.01% -1.583 pp 0.18% +0.022 pp USD15.34 +113.4% 4 qtrs
13 BALYASNY ASSET MANAGEMENT L.P. 847.5K -532.2K (-38.6%) 27.74M +3.1M (+12.7%) 1.85% -1.179 pp 0.04% +0.004 pp USD13.23 +147.4% 5 qtrs
14 NEXT CENTURY GROWTH INVESTORS LLC 799.9K +799.9K (+100.0%) 26.18M +26.2M (+100.0%) 1.74% +1.743 pp 1.82% +1.818 pp USD32.73 +0.0% 1 qtrs NEW
15 PERCEPTIVE ADVISORS LLC 784.1K +784.1K (+100.0%) 25.66M +25.7M (+100.0%) 1.71% +1.708 pp 0.46% +0.458 pp USD32.73 +0.0% 1 qtrs NEW
16 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 709.8K +220.9K (+45.2%) 23.23M +14.5M (+166.4%) 1.55% +0.474 pp 0.01% +0.008 pp USD22.35 +46.4% 9 qtrs
17 DIMENSIONAL FUND ADVISORS LP 601.8K -187.3K (-23.7%) 19.70M +5.6M (+39.9%) 1.31% -0.419 pp 0.00% +0.001 pp USD13.98 +134.1% 27 qtrs
18 DEUTSCHE BANK AG\ 589.3K +3.2K (+0.6%) 19.29M +8.8M (+84.5%) 1.28% -0.001 pp 0.01% +0.003 pp USD7.42 +341.1% 45 qtrs
19 DIVISADERO STREET CAPITAL MANAGEMENT, LP 503.8K +477.6K (+1,817.7%) 16.49M +16.0M (+3,418.3%) 1.10% +1.040 pp 0.77% +0.751 pp USD31.44 +4.1% 9 qtrs
20 GOLDMAN SACHS GROUP INC 478.6K +192.0K (+67.0%) 15.66M +10.6M (+206.4%) 1.04% +0.414 pp 0.00% +0.001 pp USD19.99 +63.7% 32 qtrs
21 DAFNA CAPITAL MANAGEMENT LLC 476.8K -265.5K (-35.8%) 15.61M +2.4M (+17.9%) 1.04% -0.589 pp 3.63% +0.354 pp USD6.91 +373.7% 17 qtrs
22 TOCQUEVILLE ASSET MANAGEMENT L.P. 469.9K -15.0K (-3.1%) 15.38M +6.7M (+77.8%) 1.02% -0.040 pp 0.22% +0.099 pp USD7.11 +360.3% 23 qtrs
23 BANK OF AMERICA CORP /DE/ 469.1K +21.1K (+4.7%) 15.35M +7.4M (+92.1%) 1.02% +0.040 pp 0.00% +0.001 pp USD14.65 +123.4% 50 qtrs
24 BESSEMER GROUP INC 465.6K -345.3K (-42.6%) 15.24M +772.0K (+5.3%) 1.01% -0.764 pp 0.02% +0.001 pp USD17.84 +83.5% 2 qtrs
25 TWO SIGMA INVESTMENTS, LP 433.5K +277.1K (+177.3%) 14.19M +11.4M (+408.7%) 0.94% +0.602 pp 0.02% +0.016 pp USD27.38 +19.5% 8 qtrs
26 FIRST EAGLE INVESTMENT MANAGEMENT, LLC 407.6K -24.3K (-5.6%) 13.34M +5.6M (+73.2%) 0.89% -0.059 pp 0.02% +0.010 pp USD14.96 +118.8% 3 qtrs
27 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 404.0K -9.3K (-2.2%) 13.22M +5.9M (+79.4%) 0.88% -0.026 pp 0.00% +0.001 pp USD17.62 +85.8% 39 qtrs
28 WCM INVESTMENT MANAGEMENT, LLC 400.6K +400.6K (+100.0%) 13.11M +13.1M (+100.0%) 0.87% +0.873 pp 0.03% +0.027 pp USD32.73 +0.0% 1 qtrs NEW
29 CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 400.5K -99.3K (-19.9%) 13.11M +4.2M (+47.0%) 0.87% -0.224 pp 0.03% +0.006 pp USD13.35 +145.2% 16 qtrs
30 JACOBS LEVY EQUITY MANAGEMENT, INC 389.3K +147.8K (+61.2%) 12.74M +8.4M (+195.7%) 0.85% +0.318 pp 0.05% +0.032 pp USD22.07 +48.3% 25 qtrs
31 NORTHERN TRUST CORP 384.3K -7.9K (-2.0%) 12.58M +5.6M (+79.8%) 0.84% -0.023 pp 0.00% +0.001 pp USD15.17 +115.8% 50 qtrs
32 BROWN CAPITAL MANAGEMENT LLC 349.2K -295.4K (-45.8%) 11.43M -70.5K (-0.6%) 0.76% -0.653 pp 0.94% +0.464 pp USD17.84 +83.5% 2 qtrs
33 HIGHMARK WEALTH MANAGEMENT LLC 343.9K +158.9K (+85.8%) 11.26M +8.0M (+240.9%) 0.75% +0.343 pp 4.59% +3.134 pp USD23.42 +39.8% 22 qtrs
34 TIMESSQUARE CAPITAL MANAGEMENT, LLC 336.8K +336.8K (+100.0%) 11.03M +11.0M (+100.0%) 0.73% +0.734 pp 0.17% +0.166 pp USD32.73 +0.0% 1 qtrs NEW
35 OBERWEIS ASSET MANAGEMENT INC/ 336.2K +8.1K (+2.5%) 11.00M +5.2M (+88.0%) 0.73% +0.013 pp 0.40% +0.178 pp USD14.74 +122.0% 8 qtrs
36 SILVERCREST ASSET MANAGEMENT GROUP LLC 293.3K -225.7K (-43.5%) 9.60M +341.1K (+3.7%) 0.64% -0.499 pp 0.07% +0.005 pp USD13.97 +134.3% 20 qtrs
37 JPMORGAN CHASE & CO 286.5K +77.5K (+37.1%) 9.38M +5.6M (+151.5%) 0.62% +0.166 pp 0.00% +0.000 pp USD18.41 +77.8% 33 qtrs
38 JANE STREET GROUP, LLC 264.5K +240.5K (+1,000.9%) 8.66M +8.2M (+1,919.8%) 0.58% +0.524 pp 0.00% +0.001 pp USD31.38 +4.3% 2 qtrs
39 PARKMAN HEALTHCARE PARTNERS LLC 250.3K -251.5K (-50.1%) 8.19M -759.8K (-8.5%) 0.55% -0.555 pp 0.78% -0.154 pp USD14.51 +125.6% 6 qtrs
40 PERKINS CAPITAL MANAGEMENT INC 228.3K -7.7K (-3.3%) 7.47M +3.3M (+77.5%) 0.50% -0.020 pp 5.93% +2.223 pp USD11.21 +192.0% 22 qtrs
41 DISCIPLINED GROWTH INVESTORS INC /MN 201.9K +34.3K (+20.5%) 6.61M +3.6M (+121.0%) 0.44% +0.072 pp 0.13% +0.072 pp USD14.63 +123.7% 3 qtrs
42 INVESCO LTD. 189.3K +87.6K (+86.1%) 6.20M +4.4M (+241.5%) 0.41% +0.189 pp 0.00% +0.001 pp USD24.84 +31.8% 24 qtrs
43 UNIPLAN INVESTMENT COUNSEL, INC. 178.6K +19.8K (+12.5%) 5.84M +3.0M (+106.4%) 0.39% +0.041 pp 0.59% +0.310 pp USD18.26 +79.2% 4 qtrs
44 F&V CAPITAL MANAGEMENT, LLC 177.0K +177.0K (+100.0%) 5.79M +5.8M (+100.0%) 0.39% +0.386 pp 0.85% +0.854 pp USD32.73 +0.0% 1 qtrs NEW
45 FMR LLC 174.0K +39.1K (+29.0%) 5.70M +3.3M (+136.7%) 0.38% +0.083 pp 0.00% +0.000 pp USD18.36 +78.3% 20 qtrs
46 TWO SIGMA ADVISERS, LP 171.0K +124.2K (+265.4%) 5.60M +4.8M (+570.3%) 0.37% +0.270 pp 0.01% +0.009 pp USD28.80 +13.6% 6 qtrs
47 ROYCE & ASSOCIATES LP 168.0K -33.0K (-16.4%) 5.50M +1.9M (+53.3%) 0.37% -0.075 pp 0.06% +0.020 pp USD17.84 +83.5% 2 qtrs
48 KOTLER KEVIN 168.0K +168.0K (+100.0%) 5.50M +5.5M (+100.0%) 0.37% +0.366 pp 1.29% +1.286 pp USD32.73 +0.0% 1 qtrs NEW
49 LEGAL & GENERAL GROUP PLC 165.5K +7.7K (+4.9%) 5.42M +2.6M (+92.4%) 0.36% +0.014 pp 0.00% +0.001 pp USD11.27 +190.4% 37 qtrs
50 D. E. SHAW & CO., INC. 160.9K -13.3K (-7.6%) 5.26M +2.2M (+69.5%) 0.35% -0.031 pp 0.00% +0.001 pp USD14.88 +120.0% 34 qtrs
51 EAM INVESTORS, LLC 155.8K +155.8K (+100.0%) 5.10M +5.1M (+100.0%) 0.34% +0.339 pp 0.57% +0.568 pp USD32.73 +0.0% 1 qtrs NEW
52 STEPHENS INVESTMENT MANAGEMENT GROUP LLC 154.1K +154.1K (+100.0%) 5.04M +5.0M (+100.0%) 0.34% +0.336 pp 0.07% +0.066 pp USD32.73 +0.0% 1 qtrs NEW
53 MARSHALL WACE, LLP 150.8K -36.5K (-19.5%) 4.94M +1.6M (+47.7%) 0.33% -0.082 pp 0.00% +0.001 pp USD17.89 +83.0% 6 qtrs
54 MARINER, LLC 149.2K -40.7K (-21.4%) 4.88M +1.5M (+44.1%) 0.33% -0.091 pp 0.01% +0.001 pp USD16.61 +97.0% 4 qtrs
55 CITADEL ADVISORS LLC 148.7K +104.4K (+235.7%) 4.87M +4.1M (+515.8%) 0.32% +0.227 pp 0.00% +0.001 pp USD28.29 +15.7% 35 qtrs
56 QUBE RESEARCH & TECHNOLOGIES LTD 142.2K -41.4K (-22.6%) 4.65M +1.4M (+42.1%) 0.31% -0.093 pp 0.00% +0.001 pp USD14.73 +122.2% 10 qtrs
57 PRIMORIS WEALTH ADVISORS, LLC 139.4K -3.7K (-2.6%) 4.56M +2.0M (+78.8%) 0.30% -0.010 pp 2.73% +1.107 pp USD17.39 +88.2% 6 qtrs
58 BANK OF NEW YORK MELLON CORP 134.7K -3.3K (-2.4%) 4.41M +1.9M (+79.1%) 0.29% -0.009 pp 0.00% +0.000 pp USD17.86 +83.3% 42 qtrs
59 PANAGORA ASSET MANAGEMENT INC 130.5K +7.7K (+6.3%) 4.27M +2.1M (+95.0%) 0.28% +0.015 pp 0.02% +0.006 pp USD10.25 +219.3% 15 qtrs
60 RAYMOND JAMES FINANCIAL INC 121.6K -32.3K (-21.0%) 3.98M +1.2M (+45.0%) 0.26% -0.073 pp 0.00% +0.000 pp USD16.48 +98.6% 5 qtrs
61 NUVEEN, LLC 121.0K +30.6K (+33.8%) 3.96M +2.3M (+145.5%) 0.26% +0.065 pp 0.00% +0.001 pp USD22.09 +48.2% 4 qtrs
62 SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 114.7K +21.4K (+22.9%) 3.75M +2.1M (+125.4%) 0.25% +0.045 pp 0.06% +0.032 pp USD20.61 +58.8% 2 qtrs
63 LISANTI CAPITAL GROWTH, LLC 109.2K +109.2K (+100.0%) 3.57M +3.6M (+100.0%) 0.24% +0.238 pp 0.85% +0.847 pp USD32.73 +0.0% 1 qtrs NEW
64 TREXQUANT INVESTMENT LP 94.3K -29.8K (-24.0%) 3.09M +873.2K (+39.4%) 0.21% -0.067 pp 0.03% +0.005 pp USD17.84 +83.5% 7 qtrs
65 SWISS NATIONAL BANK 90.8K +6.9K (+8.2%) 2.97M +1.5M (+98.6%) 0.20% +0.014 pp 0.00% +0.001 pp USD19.53 +67.6% 4 qtrs
66 UBS GROUP AG 90.8K -23.5K (-20.5%) 2.97M +932.8K (+45.8%) 0.20% -0.053 pp 0.00% +0.000 pp USD14.18 +130.8% 42 qtrs
67 PRINCIPAL FINANCIAL GROUP INC 88.5K +37.4K (+73.2%) 2.90M +2.0M (+217.7%) 0.19% +0.081 pp 0.00% +0.001 pp USD22.35 +46.4% 19 qtrs
68 COUNTERPOINT MUTUAL FUNDS LLC 87.6K +87.6K (+100.0%) 2.87M +2.9M (+100.0%) 0.19% +0.191 pp 0.21% +0.212 pp USD32.73 +0.0% 1 qtrs NEW
69 FRANKLIN RESOURCES INC 81.4K +2.5K (+3.2%) 2.67M +1.3M (+89.4%) 0.18% +0.004 pp 0.00% +0.000 pp USD9.58 +241.6% 8 qtrs
70 SUSQUEHANNA INTERNATIONAL GROUP, LLP 81.4K +44.9K (+123.0%) 2.66M +2.0M (+309.2%) 0.18% +0.097 pp 0.00% +0.000 pp USD26.05 +25.6% 8 qtrs
71 RICE HALL JAMES & ASSOCIATES, LLC 81.1K -32.5K (-28.6%) 2.66M +628.6K (+31.0%) 0.18% -0.072 pp 0.15% +0.036 pp USD7.90 +314.3% 8 qtrs
72 NEW YORK STATE COMMON RETIREMENT FUND 74.1K +60.9K (+463.5%) 2.42M +2.2M (+933.7%) 0.16% +0.133 pp 0.00% +0.003 pp USD30.06 +8.9% 39 qtrs
73 AMERIPRISE FINANCIAL INC 73.7K -60.5K (-45.1%) 2.41M +18.6K (+0.8%) 0.16% -0.134 pp 0.00% +0.000 pp USD12.34 +165.2% 35 qtrs
74 HRT FINANCIAL LP 73.1K +73.1K (+100.0%) 2.39M +2.4M (+100.0%) 0.16% +0.159 pp 0.01% +0.008 pp USD32.73 +0.0% 1 qtrs NEW
75 KENNEDY CAPITAL MANAGEMENT LLC 70.6K -81.6K (-53.6%) 2.31M -403.8K (-14.9%) 0.15% -0.180 pp 0.05% -0.011 pp USD17.05 +92.0% 19 qtrs
76 BARCLAYS PLC 69.3K -2.7K (-3.8%) 2.27M +1.3M (+124.6%) 0.15% -0.007 pp 0.00% +0.000 pp USD11.44 +186.1% 36 qtrs
77 PUBLIC SECTOR PENSION INVESTMENT BOARD 66.7K +66.7K (+100.0%) 2.18M +2.2M (+100.0%) 0.15% +0.145 pp 0.01% +0.007 pp USD32.73 +0.0% 1 qtrs NEW
78 SG AMERICAS SECURITIES, LLC 65.5K +53.8K (+459.9%) 2.14M +1.9M (+925.4%) 0.14% +0.117 pp 0.00% +0.002 pp USD30.07 +8.8% 6 qtrs
79 JUMP FINANCIAL, LLC 65.2K -58.5K (-47.3%) 2.13M -73.7K (-3.3%) 0.14% -0.129 pp 0.03% 0.000 pp USD17.84 +83.5% 6 qtrs
80 ROYAL BANK OF CANADA 62.9K +36.4K (+137.2%) 2.06M +1.6M (+335.1%) 0.14% +0.079 pp 0.00% +0.000 pp USD23.20 +41.1% 45 qtrs
81 BRADLEY FOSTER & SARGENT INC/CT 62.2K +— (+0.0%) 2.04M +926.0K (+83.5%) 0.14% -0.001 pp 0.03% +0.014 pp USD14.11 +132.0% 6 qtrs
82 UBS ASSET MANAGEMENT AMERICAS INC 60.3K +5.3K (+9.7%) 1.97M +991.8K (+101.2%) 0.13% +0.011 pp 0.00% +0.000 pp USD15.35 +113.2% 4 qtrs
83 WELLS FARGO & COMPANY/MN 59.6K +19.1K (+47.1%) 1.95M +1.2M (+169.9%) 0.13% +0.041 pp 0.00% +0.000 pp USD19.41 +68.6% 41 qtrs
84 B. METZLER SEEL. SOHN & CO. AG 59.5K +59.5K (+100.0%) 1.95M +1.9M (+100.0%) 0.13% +0.130 pp 0.02% +0.017 pp USD32.73 +0.0% 1 qtrs NEW
85 GLOBEFLEX CAPITAL L P 58.5K +— (+0.0%) 1.91M +871.0K (+83.5%) 0.13% -0.001 pp 0.29% +0.132 pp USD14.02 +133.5% 6 qtrs
86 RHUMBLINE ADVISERS 55.7K -9.2K (-14.2%) 1.82M +665.4K (+57.5%) 0.12% -0.021 pp 0.00% +0.001 pp USD15.01 +118.1% 39 qtrs
87 GABELLI FUNDS LLC 53.2K -17.9K (-25.2%) 1.74M +472.1K (+37.2%) 0.12% -0.040 pp 0.01% +0.003 pp USD10.85 +201.7% 3 qtrs
88 SEI INVESTMENTS CO 51.9K +51.9K (+100.0%) 1.70M +1.7M (+100.0%) 0.11% +0.113 pp 0.00% +0.002 pp USD32.73 +0.0% 1 qtrs NEW
89 ALLIANCEBERNSTEIN L.P. 51.2K +— (+0.0%) 1.68M +762.7K (+83.5%) 0.11% -0.001 pp 0.00% +0.000 pp USD25.86 +26.6% 35 qtrs
90 ENGINEERS GATE MANAGER LP 49.4K -16.3K (-24.8%) 1.62M +445.4K (+38.0%) 0.11% -0.036 pp 0.02% +0.006 pp USD9.75 +235.7% 12 qtrs
91 WHITE PINE CAPITAL LLC 45.9K -907.0 (-1.9%) 1.50M +667.4K (+79.9%) 0.10% -0.003 pp 0.41% +0.174 pp USD8.90 +267.8% 17 qtrs
92 PRICE T ROWE ASSOCIATES INC /MD/ 43.6K +2.9K (+7.1%) 1.43M +700.0K (+96.4%) 0.09% +0.006 pp 0.00% +0.000 pp USD13.42 +143.9% 20 qtrs
93 LEGATO CAPITAL MANAGEMENT LLC 40.4K +40.4K (+100.0%) 1.32M +1.3M (+100.0%) 0.09% +0.088 pp 0.11% +0.114 pp USD32.73 +0.0% 1 qtrs NEW
94 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 38.9K -338.0 (-0.9%) 1.27M +573.6K (+81.9%) 0.08% -0.001 pp 0.00% +0.001 pp USD17.94 +82.4% 39 qtrs
95 SQUAREPOINT OPS LLC 37.0K -38.9K (-51.3%) 1.21M -143.8K (-10.6%) 0.08% -0.086 pp 0.00% 0.000 pp USD12.20 +168.3% 24 qtrs
96 ADVISOR GROUP HOLDINGS, INC. 36.1K +35.9K (+16,530.4%) 1.18M +1.2M (+31,019.4%) 0.08% +0.078 pp 0.00% +0.002 pp USD32.62 +0.3% 24 qtrs
97 RUSSELL INVESTMENTS GROUP, LTD. 33.4K +11.9K (+55.1%) 1.09M +708.3K (+184.5%) 0.07% +0.026 pp 0.00% +0.001 pp USD22.24 +47.2% 17 qtrs
98 EXCHANGE TRADED CONCEPTS, LLC 31.9K -26.7K (-45.6%) 1.04M -2.1K (-0.2%) 0.07% -0.059 pp 0.01% -0.001 pp USD10.33 +216.8% 25 qtrs
99 METLIFE INVESTMENT MANAGEMENT, LLC 25.7K +— (+0.0%) 839.8K +382.0K (+83.5%) 0.06% 0.000 pp 0.00% +0.002 pp USD15.82 +106.9% 33 qtrs
100 ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 25.8K +25.8K (+100.0%) 799.6K +799.6K (+100.0%) 0.06% +0.056 pp 0.00% +0.001 pp USD32.73 +0.0% 1 qtrs NEW
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.40
Bearish
Ratio by volume
0.47
Bearish
Buys
4
Sells
10
Shares acquired
32.9K
Shares disposed
69.2K
Cash buys
Cash sales
6.00
Net activity
-36,323
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-08 Wendell Amy McBride Director M-Exempt A Common Stock 1,647 14.85 24.5K 95,473 D
2026-05-07 Weiler Kathy Johnson Director S-Sale D Common Stock 16,344 44.09 720.6K 0 D
2026-05-07 Quackenbush Doris Officer S-Sale D Common Stock 3,878 43.51 168.7K 92,416 D
2026-05-07 Kemp Jens Officer S-Sale D Common Stock 4,000 43.44 173.8K 72,451 D
2026-05-07 JOHNSON JOHN Director M-Exempt D Employee Stock Option (right to purchase) 11,050 7.04 77.8K 0 D
2026-05-07 Hartley Lindsey Marie Officer M-Exempt A Common Stock 2,963 8.27 24.5K 65,719 D
2026-05-01 Quackenbush Doris Officer Employee Stock Option (right to purchase) 10,285 8.60 88.5K 0 D
2026-03-16 Hartley Lindsey Marie Officer M-Exempt A Common Stock 5,000 0.00 62,702 D
2026-03-16 DeVinney Erick Wayne Officer M-Exempt A Restricted Stock Units 6,363 0.00 6,363 D
2026-03-01 Kemp Jens Officer F-InKind D Common Stock 2,952 30.65 90.5K 76,451 D
2026-03-01 DeVinney Erick Wayne Officer F-InKind D Common Stock 11,276 30.65 345.6K 252,934 D
2026-03-01 Began Marc A Officer M-Exempt A Common Stock 11,250 0.00 54,562 D
2026-02-26 Kemp Jens Officer A-Award A Restricted Stock Units 23,000 0.00 23,000 D
2026-02-26 Hartley Lindsey Marie Officer A-Award A Restricted Stock Units 23,000 0.00 23,000 D
2026-02-26 DeVinney Erick Wayne Officer A-Award A Common Stock 33,780 0.00 274,912 D
2026-02-26 DALE MICHAEL D Officer A-Award A Restricted Stock Units 98,000 0.00 98,000 D
2026-02-26 Began Marc A Officer A-Award A Restricted Stock Units 23,000 0.00 23,000 D
2026-02-22 Hartley Lindsey Marie Officer A-Award A Common Stock 17,500 0.00 51,157 D
2025-12-16 Wendell Amy McBride Director M-Exempt D Stock Option (right to purchase) 20,436 6.30 128.7K 0 D
2025-12-16 Weiler Kathy Johnson Director S-Sale D Common Stock 6,580 29.55 194.4K 0 D
2025-12-15 Hartley Lindsey Marie Officer M-Exempt D Employee Stock Option (right to purchase) 14,812 8.27 122.5K 0 D
2025-12-11 Began Marc A Officer S-Sale D Common Stock 13,222 30.00 396.7K 18,285 D
2025-12-10 DALE MICHAEL D Officer S-Sale D Common Stock 25,000 30.00 750.0K 63,537 D
2025-12-09 TYNDALL JOSEPH A. Director S-Sale D Common Stock 10,860 30.98 336.4K 0 D
2025-12-09 THOMAS PAUL Director S-Sale D Common Stock 21,399 29.61 633.7K 13,528 D
2025-12-09 Kemp Jens Officer S-Sale D Common Stock 8,156 31.21 254.5K 46,030 D
2025-12-09 JOHNSON JOHN Director S-Sale D Common Stock 13,141 29.98 394.0K 0 D
2025-12-09 DeVinney Erick Wayne Officer S-Sale D Common Stock 19,517 31.21 609.1K 241,132 D
2025-12-09 DALE MICHAEL D Officer S-Sale D Common Stock 61,463 31.21 1.92M 88,537 D
2025-12-09 Began Marc A Officer S-Sale D Common Stock 9,278 31.21 289.5K 31,507 D
2025-12-08 JOHNSON JOHN Director M-Exempt D Stock Option (right to purchase) 11,891 6.30 74.9K 8,545 D
2025-12-08 Hartley Lindsey Marie Officer M-Exempt A Common Stock 20,000 15.22 304.4K 40,763 D
2025-12-04 Kemp Jens Officer A-Award A Common Stock 22,500 0.00 54,186 D
2025-12-04 DeVinney Erick Wayne Officer A-Award A Common Stock 40,000 0.00 260,649 D
2025-12-04 DALE MICHAEL D Officer A-Award A Common Stock 150,000 0.00 150,000 D
2025-12-04 Began Marc A Officer A-Award A Common Stock 22,500 0.00 40,785 D
2025-11-11 Burke William P. Mr. Director M-Exempt D Stock Option (right to purchase) 3,591 8.14 29.2K 0 D
2025-11-10 Burke William P. Mr. Director S-Sale D Common Stock 19,227 24.01 461.6K 100 D
2025-11-06 Burke William P. Mr. Director M-Exempt D Stock Option (right to purchase) 5,347 8.14 43.5K 22,818 D
2025-11-05 Burke William P. Mr. Director M-Exempt D Stock Option (right to purchase) 11,431 8.14 93.0K 28,165 D
2025-10-30 Burke William P. Mr. Director S-Sale D Common Stock 18,248 23.00 419.7K 100 D
2025-10-29 Burke William P. Mr. Director M-Exempt D Stock Option (right to buy) 20,436 6.30 128.7K 0 D
2025-10-22 Burke William P. Mr. Director S-Sale D Common Stock 1,457 18.02 26.3K 100 D
2025-10-06 Burke William P. Mr. Director S-Sale D Common Stock 736 18.00 13.2K 1,557 D
2025-10-03 Burke William P. Mr. Director S-Sale D Common Stock 7,600 18.21 138.4K 0 I
2025-10-02 Burke William P. Mr. Director S-Sale D Common Stock 2,400 18.01 43.2K 7,600 I
2025-09-16 DeVinney Erick Wayne Officer S-Sale D Common Stock 1,137 16.29 18.5K 220,649 D
2025-09-13 DeVinney Erick Wayne Officer A-Award A Common Stock 2,500 0.00 221,786 D
2025-06-19 Wendell Amy McBride Director A-Award A Restricted Stock Units 14,150 0.00 14,150 D
2025-06-19 Weiler Kathy Johnson Director A-Award A Restricted Stock Units 14,150 0.00 14,150 D
2025-06-19 TYNDALL JOSEPH A. Director A-Award A Restricted Stock Units 14,150 0.00 14,150 D
2025-06-19 THOMAS PAUL Director A-Award A Restricted Stock Units 18,867 0.00 18,867 D
2025-06-19 Levine Alan M Director A-Award A Restricted Stock Units 14,150 0.00 14,150 D
2025-06-19 JOHNSON JOHN Director A-Award A Restricted Stock Units 14,150 0.00 14,150 D
2025-06-19 Burke William P. Mr. Director A-Award A Restricted Stock Units 14,150 0.00 14,150 D
2025-06-10 TYNDALL JOSEPH A. Director M-Exempt D Stock Option (right to purchase) 7,586 6.30 47.8K 0 D
2025-06-09 Wendell Amy McBride Director S-Sale D Common Stock 4,073 10.61 43.2K 93,826 D
2025-06-09 Weiler Kathy Johnson Director S-Sale D Common Stock 4,073 10.61 43.2K 6,580 D
2025-06-09 NEELS GUIDO J Director S-Sale D Common Stock 4,073 10.61 43.2K 86,743 D
2025-06-09 Levine Alan M Director S-Sale D Common Stock 4,073 10.61 43.2K 36,743 D
2025-06-09 JOHNSON JOHN Director S-Sale D Common Stock 4,073 10.61 43.2K 24,943 D
2025-06-09 Burke William P. Mr. Director S-Sale D Common Stock 4,073 10.61 43.2K 24,484 D
2025-05-22 TYNDALL JOSEPH A. Director M-Exempt D Stock Option (right to purchase) 12,850 6.30 81.0K 7,586 D
2025-05-19 TYNDALL JOSEPH A. Director S-Sale D Common Stock 2,525 11.63 29.4K 22,557 D
2025-05-12 Hartley Lindsey Marie Officer Common Stock 0 0.00 20,763 D
2025-03-25 Kemp Jens Officer A-Award A Restricted Stock Units 38,000 0.00 38,000 D
2025-03-25 DeVinney Erick Wayne Officer A-Award A Restricted Stock Units 38,000 0.00 38,000 D
2025-03-25 DALE MICHAEL D Officer A-Award A Restricted Stock Units 176,300 0.00 176,300 D
2025-03-25 Began Marc A Officer A-Award A Restricted Stock Units 55,000 0.00 55,000 D
2025-03-19 DeVinney Erick Wayne Officer S-Sale D Common Stock 15,111 17.50 264.4K 217,762 D
2025-03-16 DeVinney Erick Wayne Officer M-Exempt A Common Stock 23,150 0.00 232,873 D
2025-03-04 Kemp Jens Officer F-InKind D Common Stock 4,003 18.36 73.5K 27,683 D
2025-03-04 DeVinney Erick Wayne Officer F-InKind D Common Stock 8,296 18.35 152.2K 201,005 D
2025-03-04 Began Marc A Officer F-InKind D Common Stock 5,901 18.36 108.3K 18,285 D
2025-03-03 Wendell Amy McBride Director S-Sale D Common Stock 5,000 20.02 100.1K 97,899 D
2025-03-01 Began Marc A Officer D Employee Stock Option (right to purchase) 90,000 8.16 734.4K 0
2025-02-28 DeVinney Erick Wayne Officer M-Exempt A Common Stock 24,799 0.00 209,301 D
2025-02-25 Kemp Jens Officer F-InKind D Common Stock 814 16.49 13.4K 31,686 D
2025-02-25 DeVinney Erick Wayne Officer F-InKind D Common Stock 972 16.50 16.0K 184,502 D
2025-02-25 Began Marc A Officer F-InKind D Common Stock 814 16.50 13.4K 1,686 D
2025-02-22 Kemp Jens Officer M-Exempt A Common Stock 2,500 0.00 2,500 D
2025-02-22 DeVinney Erick Wayne Officer A-Award A Common Stock 2,500 0.00 185,474 D
2025-02-22 Began Marc A Officer A-Award A Common Stock 2,500 0.00 2,500 D
2025-01-06 Naor Nir Officer F-InKind D Common Stock 39,132 15.22 595.6K 260,868 D
2024-12-31 TYNDALL JOSEPH A. Director 0 0.00 0
2024-09-16 THOMAS PAUL Director A-Award A Common Stock 2,875 0.00 34,927
2024-09-13 DeVinney Erick Wayne Officer A-Award A Common Stock 2,500 0.00 179,974
2024-09-01 Wendell Amy McBride Director M-Exempt D Restricted Stock Units 11,904 0.00 0
2024-09-01 TYNDALL JOSEPH A. Director M-Exempt D Restricted Stock Units 11,904 0.00 0
2024-09-01 THOMAS PAUL Director M-Exempt A Common Stock 11,904 0.00 32,052
2024-09-01 NEELS GUIDO J Director M-Exempt A Common Stock 11,904 0.00 90,816
2024-09-01 Levine Alan M Director M-Exempt D Restricted Stock Units 11,904 0.00 0
2024-09-01 JOHNSON JOHN Director M-Exempt D Restricted Stock Units 11,904 0.00 0
2024-09-01 Burke William P. Mr. Director M-Exempt D Restricted Stock Units 11,904 0.00 0
2024-08-09 DALE MICHAEL D Director / Officer A-Award A Performance Stock Units 450,000 0.00 450,000
2024-06-06 Wendell Amy McBride Director A-Award A Stock Option (right to purchase) 18,248 7.04 128.5K 18,248
2024-06-06 Weiler Kathy Johnson Director A-Award A Common Stock 10,653 0.00 10,653
2024-06-06 TYNDALL JOSEPH A. Director A-Award A Common Stock 10,653 0.00 10,653
2024-06-06 THOMAS PAUL Director A-Award A Common Stock 10,653 0.00 20,148
2024-06-06 NEELS GUIDO J Director A-Award A Employee Stock Option (right to purchase) 18,248 7.04 128.5K 18,248
2024-06-06 Levine Alan M Director A-Award A Common Stock 10,653 0.00 28,912
2024-06-06 JOHNSON JOHN Director A-Award A Common Stock 10,653 0.00 17,112
2024-06-06 Burke William P. Mr. Director A-Award A Common Stock 10,653 0.00 16,653
2024-06-04 Freitag Gregory Gene Director M-Exempt D Restricted Stock Units 11,904 0.00 0
2024-03-21 Zaderej Karen L. Director / Officer S-Sale D Common Stock 33,028 7.68 253.7K 1,124,565
2024-03-21 Scopelianos Angelo Officer S-Sale D Common Stock 5,251 7.68 40.3K 52,999
2024-03-21 Donovan Michael Patrick Officer S-Sale D Common Stock 721 7.68 5.5K 40,221
2024-03-21 DeVinney Erick Wayne Officer S-Sale D Common Stock 3,141 7.68 24.1K 177,474
2024-03-16 Zaderej Karen L. Director / Officer M-Exempt D Restricted Stock Units 12,975 0.00 0
2024-03-16 Scopelianos Angelo Officer M-Exempt D Restricted Stock Units 2,500 0.00 0
2024-03-16 Donovan Michael Patrick Officer M-Exempt A Common Stock 2,950 0.00 40,942
2024-03-16 DeVinney Erick Wayne Officer M-Exempt A Common Stock 12,725 0.00 180,615
2024-03-07 Freitag Gregory Gene Director S-Sale D Common Stock 25,000 9.00 225.0K 271,594
2024-03-07 Donovan Michael Patrick Officer S-Sale D Common Stock 36,310 8.81 319.9K 35,708
2024-03-01 DeVinney Erick Wayne Officer A-Award A Common Stock 50,000 0.00 163,377
2024-02-22 Kemp Jens Officer A-Award A Performance Stock Units 68,600 0.00 68,600
2024-02-22 DeVinney Erick Wayne Officer A-Award A Performance Stock Units 68,600 0.00 68,600
2024-02-22 Began Marc A Officer A-Award A Performance Stock Units 68,600 0.00 68,600
2024-01-01 Naor Nir Officer A-Award A Common Stock 300,000 0.00 300,000
2024-01-01 Kemp Jens Officer D Employee Stock Option (right to purchase) 60,000 8.16 489.6K 0
2023-12-20 Weiler Kathy Johnson Director A-Award A Stock Option (right to purchase) 65,476 6.95 455.1K 65,476
2023-12-11 MARIANI PETER J Officer S-Sale D Common Stock 1,410 7.52 10.6K 74,693
2023-12-04 Naor Nir Officer 0 0.00 0
2023-10-13 Scopelianos Angelo Officer D-Return D Common Stock 1,403 4.04 5.7K 36,969
2023-10-13 MARTINEZ MARIA D. Officer D-Return D Common Stock 1,403 4.04 5.7K 30,476
2023-10-13 MARIANI PETER J Officer D-Return D Common Stock 3,263 4.04 13.2K 76,103
2023-10-13 Donovan Michael Patrick Officer D-Return D Common Stock 1,403 4.04 5.7K 72,018
2023-10-13 DeVinney Erick Wayne Officer D-Return D Common Stock 864 4.04 3.5K 113,377
2023-09-06 Wendell Amy McBride Director P-Purchase A Common Stock 10,000 6.22 62.2K 80,342
2023-09-01 Wendell Amy McBride Director A-Award A Restricted Stock Units 11,904 0.00 11,904
2023-09-01 TYNDALL JOSEPH A. Director A-Award A Restricted Stock Units 11,904 0.00 11,904
2023-09-01 THOMAS PAUL Director A-Award A Restricted Stock Units 11,904 0.00 11,904
2023-09-01 NEELS GUIDO J Director A-Award A Stock Option (right to purchase) 20,436 6.30 128.7K 20,436
2023-09-01 Levine Alan M Director A-Award A Restricted Stock Units 11,904 0.00 11,904
2023-09-01 JOHNSON JOHN Director A-Award A Restricted Stock Units 11,904 0.00 11,904
2023-09-01 Freitag Gregory Gene Director A-Award A Stock Option (right to purchase) 20,436 6.30 128.7K 20,436
2023-09-01 Burke William P. Mr. Director A-Award A Employee Stock Option (right to purchase) 20,436 6.30 128.7K 20,436
2023-08-24 Burke William P. Mr. Director A-Award A Common Stock 6,000 6.31 37.9K 6,000
2023-08-23 Burke William P. Mr. Director P-Purchase A Common Stock 10,000 6.56 65.6K 10,000
2023-08-16 NEELS GUIDO J Director P-Purchase A Common Stock 10,000 6.11 61.1K 68,259
2023-07-18 Zaderej Karen L. Director / Officer A-Award A Common Stock 22,076 0.00 1,072,746
2023-07-18 Scopelianos Angelo Officer A-Award A Common Stock 2,571 0.00 38,372
2023-07-18 MARTINEZ MARIA D. Officer A-Award A Common Stock 2,571 0.00 31,879
2023-07-18 MARIANI PETER J Officer A-Award A Common Stock 3,709 0.00 79,366
2023-07-18 Donovan Michael Patrick Officer A-Award A Common Stock 2,571 0.00 73,421
2023-07-18 DeVinney Erick Wayne Officer A-Award A Common Stock 1,579 0.00 114,241
2023-06-01 Wendell Amy McBride Director M-Exempt D Restricted Stock Units 6,459 0.00 0
2023-06-01 THOMAS PAUL Director M-Exempt D Restricted Stock Units 6,459 0.00 0
2023-06-01 NEELS GUIDO J Director M-Exempt D Restricted Stock Units 6,459 0.00 0
2023-06-01 Levine Alan M Director M-Exempt D Restricted Stock Units 6,459 0.00 0
2023-06-01 JOHNSON JOHN Director M-Exempt D Restricted Stock Units 6,459 0.00 0
2023-06-01 Freitag Gregory Gene Director M-Exempt A Common Stock 6,459 0.00 296,594
2023-05-23 Freitag Gregory Gene Director S-Sale D Common Stock 4,640 9.26 43.0K 332,115
2023-05-12 Wendell Amy McBride Director M-Exempt A Common Stock 3,750 9.22 34.6K 63,883
2023-03-20 Began Marc A Officer D Restricted Stock Units 45,000 0.00 0
2023-03-16 Zaderej Karen L. Director / Officer M-Exempt D Restricted Stock Units 12,975 0.00 12,975
2023-03-16 Scopelianos Angelo Officer A-Award A Restricted Stock Units 54,100 0.00 54,100
2023-03-16 Ottinger Bradley Officer F-InKind D Common Stock 1,836 8.27 15.2K 23,627
2023-03-16 MARTINEZ MARIA D. Officer M-Exempt A Restricted Stock Units 1,250 0.00 1,250
2023-03-16 MARIANI PETER J Officer A-Award A Employee Stock Option (right to purchase) 94,500 8.27 781.5K 94,500
2023-03-16 Donovan Michael Patrick Officer M-Exempt A Common Stock 5,900 0.00 72,685
2023-03-16 DeVinney Erick Wayne Officer M-Exempt A Restricted Stock Units 3,000 0.00 3,000
2023-02-01 MARIANI PETER J Officer M-Exempt D Employee Stock Option (right to purchase) 20,940 5.04 105.5K 0
2023-01-31 MARIANI PETER J Officer M-Exempt A Common Stock 20,939 5.04 105.5K 69,875
2023-01-30 MARIANI PETER J Officer M-Exempt D Employee Stock Option (right to purchase) 20,939 5.04 105.5K 41,879
2023-01-27 MARIANI PETER J Officer M-Exempt A Common Stock 20,940 5.04 105.5K 63,048
2023-01-26 MARIANI PETER J Officer M-Exempt D Employee Stock Option (right to purchase) 20,939 0.00 83,758
2023-01-25 MARIANI PETER J Officer M-Exempt D Employee Stock Option (right to purchase) 20,939 0.00 104,697
2022-12-27 Zaderej Karen L. Officer M-Exempt A Common Stock 4,400 0.00 1,012,695
2022-12-27 Scopelianos Angelo Officer M-Exempt A Restricted Stock Units 1,150 0.00 0
2022-12-27 MARTINEZ MARIA D. Officer F-InKind D Common Stock 286 9.44 2.7K 19,061
2022-12-27 MARIANI PETER J Officer M-Exempt A Restricted Stock Units 2,625 0.00 2,625
2022-12-27 Donovan Michael Patrick Officer F-InKind D Common Stock 286 9.44 2.7K 64,719
2022-12-27 DeVinney Erick Wayne Officer F-InKind D Common Stock 10,784 9.44 101.8K 105,968
2022-12-27 Billet Isabelle Officer M-Exempt A Restricted Stock Units 1,150 0.00 0
2022-12-15 Zaderej Karen L. Officer M-Exempt A Common Stock 26,746 5.09 136.1K 1,008,295
2022-12-15 MARIANI PETER J Officer M-Exempt D Employee Stock Option (right to purchase) 19,364 0.00 185,636
2022-12-14 MARIANI PETER J Officer M-Exempt A Common Stock 19,364 5.04 97.6K 49,062
2022-12-13 TYNDALL JOSEPH A. 0
2022-11-16 MARIANI PETER J Officer S-Sale D Common Stock 10,649 11.88 126.5K 29,698
2022-11-14 Freitag Gregory Gene Director S-Sale D Common Stock 13,000 12.74 165.6K 339,583
2022-11-08 Freitag Gregory Gene Director S-Sale D Common Stock 13,000 12.50 162.5K 352,583
2022-08-10 Freitag Gregory Gene Director S-Sale D Common Stock 8,886 9.70 86.2K 365,583
2022-08-04 Freitag Gregory Gene Director S-Sale D Common Stock 24,000 10.64 255.4K 387,515
2022-07-25 Freitag Gregory Gene Director M-Exempt D Employee Stock Option (right to purchase) 83,000 0.00 0
2022-07-19 Burke William P. Mr. Director A-Award A Stock Option (right to purchase) 59,395 8.14 483.5K 0
2022-07-18 Zaderej Karen L. Officer D-Return D Common Stock 9,081 8.40 76.3K 981,549
2022-07-18 Scopelianos Angelo Officer A-Award A Common Stock 2,571 0.00 22,751
2022-07-18 Sandberg Eric Officer D-Return D Common Stock 1,125 8.40 9.5K 16,081
2022-07-18 MARTINEZ MARIA D. Officer D-Return D Common Stock 657 8.40 5.5K 18,197
2022-07-18 MARIANI PETER J Officer A-Award A Common Stock 3,710 0.00 38,294
2022-07-18 Donovan Michael Patrick Officer A-Award A Common Stock 2,571 0.00 64,512
2022-07-18 DeVinney Erick Wayne Officer A-Award A Common Stock 1,579 0.00 94,157
2022-07-18 Billet Isabelle Officer D-Return D Common Stock 751 8.40 6.3K 24,242
2022-07-11 Burke William P. Mr. Director 0 0.00 0
2022-06-01 Wendell Amy McBride Director A-Award A Stock Option (right to purchase) 11,811 9.29 109.7K 11,811
2022-06-01 THOMAS PAUL Director A-Award A Stock Option (right to purchase) 11,811 0.00 11,811
2022-06-01 Ottinger Bradley Officer F-InKind D Common Stock 3,775 0.00 14,798
2022-06-01 NEELS GUIDO J Director M-Exempt A Common Stock 3,036 0.00 51,800
2022-06-01 Levine Alan M Director M-Exempt A Common Stock 3,036 0.00 11,800

Executive team

Top executives
EBIT / Employee
-17.7K
Shares Outstanding
53.18M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Michael Dale CEO and President 775.9K 7.34M 906.1K 22.6K 9.05M 81.16%
2 2025 Marc Began Executive Vice President and GC 439.1K 2.29M 307.7K 26.0K 3.06M 74.78%
3 2025 Jens Kemp Chief Marketing Officer 395.2K 1.58M 276.9K 24.4K 2.28M 69.44%
4 2025 Erick DeVinney Chief Innovation Officer 414.6K 1.58M 242.1K 22.3K 2.26M 69.98%
5 2025 Lindsey Hartley CFO 395.1K 1.30M 217.5K 20.2K 1.94M 67.30%
6 2025 Nir Naor Former CFO 228.2K 43.4K 271.5K 0.00%
7 2024 Michael Dale CEO and President 303.2K 8.03M 509.5K 10.3K 8.85M 90.70%
8 2024 Nir Naor Former CFO 475.1K 2.07M 477.8K 22.9K 3.05M 67.99%
9 2024 Nir Naor CFO 475.1K 2.07M 477.8K 22.9K 3.05M 67.99%
10 2024 Karen Zaderej Former CEO and President 439.6K 735.4K 1.30M 2.48M 0.00%
11 2024 Erick DeVinney Chief Innovation Officer 400.3K 1.51M 335.5K 22.3K 2.27M 66.55%
12 2024 Marc Began Executive Vice President and GC 423.9K 974.0K 426.3K 23.4K 1.85M 52.72%
13 2024 Marc Began EVP, GC 423.9K 974.0K 426.3K 23.4K 1.85M 52.72%
14 2024 Jens Kemp Chief Marketing Officer 374.4K 974.0K 376.5K 21.1K 1.75M 55.79%
15 2023 Karen Zaderej CEO and President 700.0K 3.16M 886.1K 763.7K 25.8K 5.53M 73.09%
16 2023 Karen Zaderej Former CEO and President 700.0K 3.16M 886.1K 763.7K 25.8K 5.53M 73.09%
17 2023 Peter Mariani Executive Vice President, CFO 473.0K 1.04M 467.8K 932.3K 2.91M 51.74%
18 2023 Angelo Scopelianos, Ph.D. Chief Research and Development Officer 419.1K 695.5K 386.1K 228.6K 90.2K 1.82M 59.45%
19 2023 Michael Donovan Vice President, Operations 375.0K 649.2K 314.3K 204.6K 23.8K 1.57M 61.49%
20 2023 Erick DeVinney Vice President , Peripheral Nerve Science 348.0K 631.0K 316.8K 189.8K 20.1K 1.51M 62.95%
21 2023 Erick DeVinney Chief Innovation Officer 348.0K 631.0K 316.8K 189.8K 20.1K 1.51M 62.95%
22 2023 Nir Naor Former CFO 36.4K 23.9K 60.3K 0.00%
23 2023 Nir Naor CFO 36.4K 23.9K 60.3K 0.00%
24 2022 Karen Zaderej CEO and President 674.0K 2.13M 1.42M 162.0K 16.2K 4.40M 80.62%
25 2022 Karen Zaderej President, CEO 674.0K 2.13M 1.42M 162.0K 16.2K 4.40M 80.62%
26 2022 Karen Zaderej Former CEO and President 674.0K 2.13M 1.42M 162.0K 16.2K 4.40M 80.62%
27 2022 Peter Mariani Executive Vice President , CFO 457.3K 1.12M 461.8K 60.4K 14.8K 2.12M 74.83%
28 2022 Peter Mariani Executive Vice President, CFO 457.3K 1.12M 461.8K 60.4K 14.8K 2.12M 74.83%
29 2022 Eric Sandberg Former Chief Commercial Officer 214.9K 843.9K 271.4K 581.9K 1.91M 58.33%
30 2022 Angelo Scopelianos, Ph.D. Chief Research and Development Officer 406.9K 554.0K 181.8K 48.9K 85.2K 1.27M 58.04%
31 2022 Bradley Ottinger General Counsel and Chief Compliance Officer 389.5K 573.8K 192.1K 46.8K 13.6K 1.22M 62.99%
32 2022 Michael Donovan Vice President, Operations 349.2K 510.5K 159.1K 42.0K 14.8K 1.08M 62.25%
33 2022 Michael Donovan Vice President of Operations 349.2K 510.5K 159.1K 42.0K 14.8K 1.08M 62.25%
34 2021 Karen Zaderej President, CEO 651.2K 3.36M 848.0K 499.3K 6.0K 5.36M 78.42%
35 2021 Karen Zaderej CEO and President 651.2K 3.36M 848.0K 499.3K 6.0K 5.36M 78.42%
36 2021 Peter Mariani Executive Vice President, CFO 438.3K 1.28M 675.3K 186.9K 71.3K 2.65M 73.69%
37 2021 Peter Mariani Executive Vice President , CFO 438.3K 1.28M 675.3K 186.9K 71.3K 2.65M 73.69%
38 2021 Angelo Scopelianos, Ph.D. Chief Research and Development Officer 394.7K 591.8K 376.4K 151.4K 67.9K 1.58M 61.19%
39 2021 Eric Sandberg Chief Commercial Officer 364.0K 740.2K 260.1K 153.4K 11.6K 1.53M 65.41%
40 2021 Eric Sandberg Former Chief Commercial Officer 364.0K 740.2K 260.1K 153.4K 11.6K 1.53M 65.41%
41 2021 Maria Martinez Chief Human Resources Officer 352.0K 767.4K 260.1K 135.0K 11.6K 1.53M 67.33%
42 2020 Karen Zaderej President, CEO 560.8K 2.16M 351.3K 967.0K 10.7K 4.05M 62.02%
43 2020 Peter Mariani Executive Vice President , CFO 361.8K 502.6K 188.6K 434.0K 1.49M 46.48%
44 2020 Peter Mariani CFO 361.8K 502.6K 188.6K 434.0K 1.49M 46.48%
45 2020 Bradley Ottinger General Counsel and Chief Compliance Officer 332.6K 25.0K 442.3K 318.9K 150.2K 35.9K 1.30M 58.34%
46 2020 Eric Sandberg CCO 315.0K 482.4K 105.1K 298.7K 93.0K 1.29M 45.40%
47 2020 Eric Sandberg Chief Commercial Officer 315.0K 482.3K 105.1K 298.7K 93.0K 1.29M 45.39%
48 2020 Eric Sandberg Former Chief Commercial Officer 315.0K 482.3K 105.1K 298.0K 93.0K 1.29M 45.42%
49 2020 Angelo Scopelianos Chief Research & Development Officer 332.6K 398.3K 105.1K 286.7K 76.3K 1.20M 41.99%
50 2020 Angelo Scopelianos, Ph.D. Chief Research and Development Officer 332.6K 398.3K 105.1K 286.7K 76.3K 1.20M 41.99%
51 2020 Brad Ottinger General Counsel and Chief Compliance Officer 176.0K 25.0K 442.3K 318.9K 150.2K 35.9K 1.15M 66.29%
52 2020 Maria Martinez Chief Human Resources Officer 304.7K 355.2K 105.1K 262.6K 11.4K 1.04M 44.31%
53 2019 Eric Sandberg, CCO 323.1K 122.7K 283.0K 373.1K 11.6K 1.11M 58.92%
54 2019 Eric Sandberg CCO 323.1K 283.0K 373.1K 122.7K 11.6K 1.11M 58.92%
55 2019 Eric Sandberg Chief Commercial Officer 323.1K 283.0K 373.1K 122.7K 11.6K 1.11M 58.92%
56 2019 Karen Zaderej President, CEO 605.0K 382.6K 12.4K 1,000.0K 0.00%
57 2019 Angelo Scopelianos, Ph.D. Chief Research and Development Officer 357.7K 119.8K 76.7K 554.1K 0.00%
58 2019 Angelo Scopelianos VP, Research & Development 357.7K 119.8K 76.7K 554.1K 0.00%
59 2019 Angelo Scopelianos Chief Research & Development Officer 357.7K 119.8K 76.7K 554.1K 0.00%
60 2019 Peter Mariani, CFO 390.1K 145.1K 12.8K 548.0K 0.00%
61 2019 Peter Mariani Executive Vice President , CFO 390.1K 145.1K 12.8K 548.0K 0.00%
62 2019 Peter Mariani CFO 390.1K 145.1K 12.8K 548.0K 0.00%
63 2019 Maria Martinez, Chief Human Resource Officer 326.9K 121.6K 12.0K 460.5K 0.00%
64 2019 Maria Martinez Chief Human Resources Officer 326.9K 121.6K 11.2K 459.7K 0.00%
65 2018 Karen Zaderej President, CEO 575.0K 2.07M 593.4K 419.2K 12.0K 3.67M 72.55%
66 2018 Angelo Scopelianos Chief Research & Development Officer 127.6K 693.8K 625.8K 50.2K 23.2K 1.52M 86.78%
67 2018 Angelo Scopelianos VP, Research & Development 127.6K 50.2K 693.8K 625.8K 23.2K 1.52M 86.78%
68 2018 Peter Mariani, CFO 361.2K 158.0K 491.7K 415.5K 12.6K 1.44M 63.04%
69 2018 Peter Mariani CFO 361.2K 491.7K 415.5K 158.0K 12.6K 1.44M 63.04%
70 2018 Maria Martinez, Chief Human Resource Officer 50.0K 24.5K 432.7K 495.8K 2.1K 1.01M 92.37%
71 2018 Gregory Freitag, General Counsel 259.0K 113.5K 289.5K 183.9K 10.7K 856.6K 55.26%
72 2018 Jon Gingrich, CCO 325.1K 142.2K 12.6K 479.9K 0.00%
73 2018 Shawn McCarrey, SVP of Sales 213.2K 198.2K 13.2K 424.7K 0.00%
74 2017 Karen Zaderej President, CEO 462.5K 330.7K 1.90M 1.00M 4.8K 3.70M 78.46%
75 2017 Jon Gingrich, CCO 141.5K 89.8K 704.4K 1.40M 5.1K 2.34M 89.90%
76 2017 Peter Mariani, CFO 336.0K 147.8K 558.9K 602.1K 11.3K 1.66M 70.10%
77 2017 Gregory Freitag, General Counsel 189.0K 83.2K 299.7K 295.7K 7.9K 875.4K 68.01%
78 2017 Gregory Freitag General Counsel and SVP of Business Development 189.0K 83.2K 299.7K 295.7K 7.9K 875.4K 68.01%
79 2017 Shawn McCarrey, SVP of Sales 206.0K 224.1K 243.6K 120.4K 15.2K 809.2K 44.98%
80 2016 Karen Zaderej President, CEO 405.0K 244.8K 803.7K 940.7K 11.2K 2.41M 72.52%
81 2016 Peter Mariani, CFO 263.4K 114.8K 213.0K 1.08M 11.9K 1.68M 76.79%
82 2016 Shawn McCarrey, SVP of Sales 200.0K 238.6K 128.0K 224.5K 16.7K 807.8K 43.64%
83 2016 Gregory Freitag, General Counsel 228.9K 67.0K 94.0K 282.7K 10.4K 683.0K 55.16%
84 2016 Gregory Freitag General Counsel and SVP of Business Development 228.9K 67.0K 94.0K 282.7K 10.4K 683.0K 55.16%
85 2016 Gregory G. Freitag General Counsel and SVP of Business Development 228.9K 67.0K 94.0K 282.7K 10.4K 683.0K 55.16%
86 2015 Karen Zaderej President, CEO 353.8K 157.3K 521.5K 8.2K 1.04M 50.11%
87 2015 Shawn McCarrey SVP Sales 200.0K 174.3K 214.3K 15.1K 603.7K 35.49%
88 2015 Shawn McCarrey, SVP of Sales 200.0K 184.3K 104.5K 14.7K 508.6K 20.55%
89 2015 Lee Robert Johnston, Jr. CFO 489.2K 5.5K 494.7K 0.00%
90 2015 Gregory G. Freitag CFO, General Counsel and SVP of Business Development 218.9K 84.1K 173.3K 6.5K 482.8K 35.89%
91 2015 Gregory Freitag General Counsel and SVP of Business Development 218.9K 84.1K 173.3K 6.5K 482.8K 35.89%
92 2015 Gregory G. Freitag General Counsel and SVP of Business Development 218.9K 84.1K 173.3K 6.5K 482.8K 35.89%
93 2014 Karen Zaderej CEO 324.0K 149.2K 30.1K 258.0K 7.8K 769.2K 37.46%
94 2014 Karen Zaderej President, CEO 324.0K 149.2K 30.1K 258.0K 7.8K 769.2K 37.46%
95 2014 Gregory G. Freitag CFO, General Counsel and SVP of Business Development 208.2K 118.6K 30.1K 190.8K 7.2K 554.9K 39.80%
96 2014 Gregory G. Freitag Former CFO and General Counsel and SVP Of Business Development 208.2K 118.6K 30.1K 190.8K 7.2K 554.9K 39.80%
97 2014 Lee Robert Johnston, Jr. CFO 163.9K 56.9K 327.8K 5.2K 553.8K 59.18%
98 2014 Lee Robert Johnston, Jr. Chief Financial Officer 163.9K 56.9K 327.8K 5.2K 553.8K 59.18%
99 2014 Shawn McCarrey SVP Sales 200.0K 184.3K 79.3K 14.7K 478.2K 16.57%
100 2014 Jill Schiaparelli Chief Marketing Officer 235.2K 76.5K 94.5K 7.4K 413.6K 22.84%
101 2013 Shawn McCarrey SVP Sales 161.5K 153.1K 144.5K 11.9K 471.1K 30.68%
102 2013 Karen Zaderej CEO 299.6K 14.9K 8.1K 322.6K 0.00%
103 2013 Gregory G. Freitag Former CFO and General Counsel and SVP Of Business Development 240.0K 11.6K 7.6K 259.3K 0.00%
104 2013 Jill Schiaparelli Chief Marketing Officer 220.2K 11.0K 6.9K 238.0K 0.00%
105 2012 Jill Schiaparelli Senior Vice President Business Strategy and Marketing 173.7K 6.2K 208.7K 5.4K 393.9K 52.98%
106 2012 Karen Zaderej CEO 291.2K 11.6K 7.9K 310.7K 0.00%
107 2012 Gregory G. Freitag Former CEO and CFO and General Counsel 204.1K 8.2K 5.6K 217.8K 0.00%
108 2012 John P. Engels Vice President 174.9K 8.7K 5.6K 189.2K 0.00%
109 2011 Karen Zaderej CEO 252.4K 23.3K 516.7K 7.5K 799.9K 64.60%
110 2011 Gregory G. Freitag Former CEO and CFO and General Counsel 154.8K 100.0K 172.9K 427.7K 40.42%
111 2011 John P. Engels Vice President 171.1K 16.8K 122.0K 5.5K 315.4K 38.68%
112 2009 Judd A. Berlin Chief Executive Officer, Chief Financial Officer and Director 200.0K 200.0K 0.00%
113 2008 Judd A. Berlin Chief Executive Officer, Chief Financial Officer and Director 263.5K 263.5K 100.00%
114 2007 Judd A. Berlin Chief Executive Officer and Chief Financial Officer
115 2006 Judd A. Berlin Chief Executive Officer and Chief Financial Officer
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-29 DEF 14A
2025-04-30 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-12 4
2026-05-08 4
2026-05-08 4
2026-05-08 4
2026-05-08 4
2026-05-08 4
2026-05-08 3
2026-05-07 SC 13G/A
2026-04-29 SC 13G
2026-04-29 DEF 14A

Executive team

NameTitleCompensationGender
Michael D. Dale President, Chief Executive Officer & Director 2M male
Marc A. Began Executive VP, General Counsel, Secretary & Chief Compliance Officer 772.7K male
Jens Schroeder Kemp Chief Marketing Officer 696.5K male
Erick DeVinney Chief Innovation Officer 679.0K male
Lindsey Hartley Chief Financial Officer 632.8K female
Craig A. Swandal Vice President of Operations 406.0K male
Ivica Ducic Chief Medical Officer
Harold D. Tamayo Vice President of Finance & Investor Relations male
Doris Quackenbush Vice President of Sales female
ESG Rating
B
MEDICAL - DEVICES
Rank: 26 out of 168
2009
E (Environmental)
52.7 / 62.5
Company / Sector avg.
S (Social)
61.3 / 68.9
Company / Sector avg.
G (Governance)
69.1 / 64.8
Company / Sector avg.
ESG Total
61.0 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2019-06-24 2020-04-27 Donna Shalala FL27 -- Sale (Full) $1,001 - $15,000
2019-04-16 2020-04-27 Donna Shalala FL27 -- Purchase $1,001 - $15,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits